| Gary Lu, MD, PHD | |
|
2600 Scripture St, Denton, TX 76201-4315 | |
| (940) 382-1022 | |
| (940) 323-1190 |
| Full Name | Gary Lu |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 22 Years |
| Location | 2600 Scripture St, Denton, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588906457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD461935 (Pennsylvania) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | Q0109 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Presbyterian Hospital Denton | Denton, TX | Hospital |
| Medical City Denton | Denton, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Oncology Pa | 5395658934 | 855 |
News Archive
Nektar Therapeutics reports Baxter International Inc. today announced positive results from its Phase 3 pivotal clinical trial of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)], which met its primary endpoint in reducing annualized bleed rates (ABR) in the prophylaxis arm compared to the on-demand arm.
Two million of the five million Americans admitted to intensive care units annually have or develop acute respiratory failure, predisposing them to long-term cognitive, functional and psychological impairments collectively known as post-intensive care syndrome.
A new non-surgical post-mortem technique that has the potential to revolutionise the way autopsies are conducted around the world has been pioneered by forensic pathologists and radiologists at the University of Leicester in collaboration with the University Hospitals of Leicester NHS Trust.
Pretreatment interstitial lung disease (ILD) is a significant risk factor for developing symptomatic and severe radiation pneumonitis in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT) alone.
"Like a book in which the single pages are not all different but carry small portions of common text, or like a group of people who whistle a very similar tune": this is how our brain cells work, say scientists. It is the phenomenon of "co-relation", in which individual neurons do not always act as independent units in receiving and transmitting information but as a group of individuals with similar and simultaneous actions.
› Verified 5 days ago
| Entity Name | Texas Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944101 PECOS PAC ID: 5395658934 Enrollment ID: O20031124000323 |
News Archive
Nektar Therapeutics reports Baxter International Inc. today announced positive results from its Phase 3 pivotal clinical trial of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)], which met its primary endpoint in reducing annualized bleed rates (ABR) in the prophylaxis arm compared to the on-demand arm.
Two million of the five million Americans admitted to intensive care units annually have or develop acute respiratory failure, predisposing them to long-term cognitive, functional and psychological impairments collectively known as post-intensive care syndrome.
A new non-surgical post-mortem technique that has the potential to revolutionise the way autopsies are conducted around the world has been pioneered by forensic pathologists and radiologists at the University of Leicester in collaboration with the University Hospitals of Leicester NHS Trust.
Pretreatment interstitial lung disease (ILD) is a significant risk factor for developing symptomatic and severe radiation pneumonitis in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT) alone.
"Like a book in which the single pages are not all different but carry small portions of common text, or like a group of people who whistle a very similar tune": this is how our brain cells work, say scientists. It is the phenomenon of "co-relation", in which individual neurons do not always act as independent units in receiving and transmitting information but as a group of individuals with similar and simultaneous actions.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gary Lu, MD, PHD Po Box 911230, Dallas, TX 75391-1230 Ph: (972) 997-8000 | Gary Lu, MD, PHD 2600 Scripture St, Denton, TX 76201-4315 Ph: (940) 382-1022 |
News Archive
Nektar Therapeutics reports Baxter International Inc. today announced positive results from its Phase 3 pivotal clinical trial of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)], which met its primary endpoint in reducing annualized bleed rates (ABR) in the prophylaxis arm compared to the on-demand arm.
Two million of the five million Americans admitted to intensive care units annually have or develop acute respiratory failure, predisposing them to long-term cognitive, functional and psychological impairments collectively known as post-intensive care syndrome.
A new non-surgical post-mortem technique that has the potential to revolutionise the way autopsies are conducted around the world has been pioneered by forensic pathologists and radiologists at the University of Leicester in collaboration with the University Hospitals of Leicester NHS Trust.
Pretreatment interstitial lung disease (ILD) is a significant risk factor for developing symptomatic and severe radiation pneumonitis in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT) alone.
"Like a book in which the single pages are not all different but carry small portions of common text, or like a group of people who whistle a very similar tune": this is how our brain cells work, say scientists. It is the phenomenon of "co-relation", in which individual neurons do not always act as independent units in receiving and transmitting information but as a group of individuals with similar and simultaneous actions.
› Verified 5 days ago
Jamal Mubarak, M.D. Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 209 N. Bonnie Brae Street, Suite 300, Denton, TX 76201 Phone: 940-382-5864 Fax: 940-382-3939 | |
Dr. Seema Haq, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3300 Colorado Blvd, Denton, TX 76210 Phone: 940-488-4767 Fax: 855-444-9702 | |
Asad Zamann, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3315 Colorado Blvd, Ste 102, Denton, TX 76210 Phone: 940-320-1708 Fax: 940-565-5457 | |
Dr. Awilda Michelle Luciano, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2665 Scripture Street, Denton, TX 76201 Phone: 940-387-8763 Fax: 940-535-5901 | |
Dr. Ajit M Dave, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3327 Colorado Blvd, Suite #200, Denton, TX 76210 Phone: 940-382-4060 Fax: 940-380-9282 | |
Dr. Sridhar Krishnamurthy Iyer, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 802 North Bonnie Brae Street, Suite 104, Denton, TX 76201 Phone: 940-565-0373 Fax: 940-565-0413 | |
Charles Hancock Wahlert, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 521 Bryan St, Denton, TX 76201 Phone: 940-380-1985 |